Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease

World Journal of Pediatrics

Volumn 4, Issue 4, 2008, Pages 274-282

  Iwona, Ben Skowronek ^a   Jadwiga, Sierocinska Sawa ^a   Elzbieta, Korobowicz ^a   Leszek, Szewczyk ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Graves' disease; Lymphocyte subsets; Thyroid

Indexed keywords

CD3 ANTIBODY; CD4 ANTIBODY; CD4 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; LEVOTHYROXINE; MONOCLONAL ANTIBODY; THIAMAZOLE;

ADOLESCENT; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE; THYROID CELL; THYROIDECTOMY; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMANS; LYMPHOCYTE COUNT; MALE; PROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; THYROID GLAND; THYROIDECTOMY;

EID: 58149199647     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-008-0050-6     Document Type: Article

References (50)

1. Weetmann AP, De Groot LJ, The thyroid and its diseases. book chapters. 2007. www.endotext.org (accessed August 1, 2007).
2. Segundo C, Rodríguez C, Aguilar M, García-Poley A, Gavilán I, Bellas C, et al. Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: Relationship to autoantibody detection. Thyroid 2004;14:337-344.
3. Ben-Skowronek I, Walter-Croneck B, Szewczyk L. Analysis of thyroid autoantibodies and lymphocyte subsets at girls with hyperthyroidism. Proceedings of the 24th Annual Meeting of the European Thyroid Association; 1997 Aug 30-Sept 1; Munich, Germany. J Endocrinol Invest 1997;20:5 Suppl.
4. Ben-Skowronek I, Walter Croneck B, Szewczyk L. The increase of thyroid autoantibodies and CD5+B cells in children with Graves' disease. Proceedings of the 37th Annual Meeting of the European Society for Pediatrics Endocrinology (ESPE); 1998 Sept 24-27; Florence, Italy. Horm Res 1998; 50:3 Suppl.
5. Bossowski A, Urban M, Stasiak-Barmuta A, Turowski D. Expression of very late antigen-4 and lymphocyte function-associated antigen-1 on peripheral blood lymphocytes from patients with graves disease. Pediatr Res 2002;52:533-537.
6. Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity 2003;36:351-359.
7. Golab J, Circulatin of lymphocytes. In: Golab J, Jakobisiak M, Lasek W, eds. Immunology. Warsaw: PWN, 2002: 103-117.
8. Stassi G, Di Liberto D, Todaro M, Zeuner A, Ricci-Vitiani L, Stoppacciaro A, et al. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat Immunol 2000;1:483-488.
9. Stassi G, De Maria R. Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev Immunol 2002;2:195-204.
10. Hasselbach HC. B-cell depletion with rituximab - a targeted therapy for Graves' disease and autoimmune thyroiditis. Immunol Lett 2003;88:85-86.
11. Salvi M, Vannucchi G, Campi I, Currò N, Dazzi D, Simonetta S, et al. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: An open study. Eur J Endocrinol 2007;156:33-40.
12. Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 2006;147:4561-4568.
13. Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, et al. Maturation of thyroidal dendritic cells in Graves' disease. Scand J Immunol 2002;55:612-620.
14. Marazuela M. Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol 1999;140:287-290.
15. Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sanchez-Madrid F, de Landázuri MO. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur J Immunol 1994;24:2483-2490.
16. Guerin V, Bene MC, Amiel C, Hartemann P, Leclere J, Faure G. Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease. Clin Endocrinol Metab 1989;69:648-653.
17. Lee JH, An MA, Jeon JS, Song CU, Shong M, Kim YK, et al. Circulating intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease and Hashimoto disease. Korean J Inten Med 1995;10:10-15.
18. Jungheim K, Caspar G, Usadel KH, Schumm-Draeger PM. Lymphocyte homing in xenotransplanted human thyroid tissue can be inhibited by LFA-1 and ICAM-1 antibodies. Thyroid 2004;14:3-11.
19. Kabel PJ, Voorbij HA, De Haan M, van der Gaag RD, Drexhage HA. Intrathyroidal dendritic cells. J Clin Endocrinol Metab 1988;66:199-207.
20. Voorby HA, Kabel PJ, de Haan M, Jeucken PH, van der Gaag RD, de Baets MH, et al. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 1990;55:9-22.
21. Mooij P, de Wit HJ, Drexhage HA. An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopathol 1993;69:189-198.
22. Braley-Mullen H, Yu S. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J Immunol 2000;165:7262-7269.
23. Mölne J, Jansson S, Ericson LE, Nilsson M. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease. Autoimmunity 1994;17:59-71.
24. Pichurin P, Aliesky H, Chen CR, Nagayama Y, Rapoport B, McLachlan SM. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease. Clin Exp Immunol 2003;134:396-402.
25. Macht LM, Corrall RJ, Banga JP, Elson CJ. Control of human thyroid autoantibody production in SCID mice. Clin Exp Immunol 1993;91:390-396.
26. Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, et al. Marked increase of CD5+ B cells in hyperthyroid Graves' disease. Clin Exp Immunol 1989;78:196-200.
27. Bossowski A, Urban M, Stasiak-Barmuta A. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metab 2003;16:63-70.
28. Segundo C, Rodríguez C, García-Poley A, Aguilar M, Gavilán I, Bellas C, et al. Thyroid-infiltrating B lymphocytes in Graves' disease are related to marginal zone and memory B cell compartments. Thyroid 2001;11:525-530.
29. Armengol MP, Juan M, Lucas-Martín A, Fernández-Figueras MT, Jaraquemada D, Gallart T, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokinecontaining active intrathyroidal germinal centers. Am J Pathol 2001;159:861-873.
30. Leyendeckers H, Voth E, Schicha H, Hunzelmann N, Banga P, Schmitz J. Frequent detection of thyroid peroxidase-specific IgG+ memory B cells in blood of patients with autoimmune thyroid disease. Eur J Immunol 2002;32:3126-3132.
31. El Fassi D, Nielsen CH, Hasselbalch HC, Hegedüs L. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur J Endocrinol 2006;154:623-632.
32. Sridama V, Pacini F, DeGroot LJ. Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab 1982;54:316-319.
33. Pacini F, DeGroot LJ. Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: Reduced T-suppressor cell activity in Graves' disease. Clin Endocrinol (Oxf) 1983;18:219-232.
34. Misaki T, Konishi J, Iida Y, Endo K, Torizuka K. Altered balance of immunoregulatory T lymphocyte subsets in autoimmune thyroid diseases. Acta Endocrinol (Copenh) 1984;105:200-204.
35. Ludgate ME, McGregor AM, Weetman AP, Ratanachaiyavong S, Lazarus JH, Hall R, et al. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed) 1984;288(6416):526-530.
36. McLachlan SM, Pichurin PN, Nagayama Y, Aliesky HA, Chen CR, Rapoport B. Tolerance, regulatory T cells and autoimmunity to the thyrotropin receptor: Insight from transgenic mice expressing the human TSHR A subunit in the thyroid. Proceeding of the 77th Annual Meeting American Thyroid Association; 2006 Oct 11-15; Phoenix, USA. Thyroid 2006;16:823-856.
37. Saitoh O, Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 2006;147:2417-2422.
38. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-352.
39. Beissert S, Schwarz A, Schwarz T. Regulatory T cells. J Invest Dermatol 2006;126:15-24.
40. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H. Essential roles of CD8+ CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004;200:1123-1134.
41. Endharti AT, Rifa'I M 1st, Shi Z, Fukuoka Y, Nakahara Y, Kawamoto Y, et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005;175:7093-7097.
42. Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B. Schistosoma mansoni and alphagalactosylceramide: Prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 2004;173:2167-2173.
43. Marazuela M, García-Lopez MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sánchez B, Monsiváis-Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 2006;91:3639-3646.
44. Nakano A, Watanabe M, Iida T, Kuroda S, Matsuzuka F, Miyauchi A, et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid 2007;17:25-31.
45. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677-688.
46. Steinmann L. A brief history of Th 17, the first major revision in the Th1/Th2 hypothesis of cell mediated tissue damage. Nat Med 2007;13:139-145.
47. Butscher WG, Ladenson PW, Burek CL. Whole-blood proliferation assay for autoimmune thyroid disease: Comparison to density-gradient separated-peripheral blood lymphocytes. Thyroid 2001;11:531-537.
48. Metcalfe RA, Oh YS, Stroud C, Arnold K, Weetman AP. Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease. Autoimmunity 1997;25:65-72.
49. Arao T, Morimoto I, Kakinuma A, Ishida O, Zeki K, Tanaka Y, et al. Thyrocyte proliferation by cellular adhesion to infiltrating lymphocytes through the intercellular adhesion molecule-1/lymphocyte function-associated antigen-1 pathway in Graves' disease. J Clin Endocrinol Metab 2000;85:382-389.
50. Hidaka Y, Amino N, Iwatani Y, Kaneda T, Nasu M, Mitsuda N, et al. Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 1992;11:239-246.